Article citationsMore>>

Reichardt, P., Blay, J.Y., Gelderblom, H., Schlemmer, M., Demetri, G.D., Bui-Nguyen, B., et al. (2012) Phase III Study of Nilotinib versus Best Supportive Care with or without a TKI in Patients with Gastrointestinal Stromal Tumors Resistant to or Intolerant of Imatinib and Sunitinib. Annals of Oncology, 23, 1680-1687. http://dx.doi.org/10.1093/annonc/mdr598

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top